Douglas Sborov, MD, MS, Director of the Multiple Myeloma Program, Huntsman Cancer Institute at the University of Utah, discusses the impact of the COVID-19 pandemic on treatment and care for patients with multiple myeloma, and suggestions for these patients regarding vaccination.